Leemore Dafny

Q: What Schools Are Affiliated With Leemore Dafny

Leemore Dafny is affiliated with the following schools: Northwestern University, Massachusetts Institute of Technology, Harvard University

Leemore Dafny's AcademicInfluence.com Rankings

Leemore Dafny

Economics

#3382

World Rank

#3834

Historical Rank

economics Degrees

Download Badge

Economics

Why Is Leemore Dafny Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Leemore S. Dafny is an American economist currently the Bruce V. Rauner Professor of Business Administration at Harvard Business School and a member of the faculty at John F. Kennedy School of Government. She graduated from Harvard College and received a PhD in Economics from Massachusetts Institute of Technology.

(See a Problem?)

Leemore Dafny's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

How Do Hospitals Respond to Price Changes? (2003) (382)
Paying a Premium on Your Premium? Consolidation in the U.S. Health Insurance Industry (2009) (281)
Estimation and Identification of Merger Effects: An Application to Hospital Mergers (2005) (221)
Are Health Insurance Markets Competitive? (2008) (183)
Do Report Cards Tell Consumers Anything They Don&Apos;T Already Know? the Case of Medicare Hmos (2005) (181)
Public insurance and child hospitalizations: access and efficiency effects (2005) (169)
Hospital industry consolidation--still more to come? (2014) (113)
More Insurers Lower Premiums: Evidence from Initial Pricing in the Health Insurance Marketplaces (2014) (108)
Decreases In Readmissions Credited To Medicare's Program To Reduce Hospital Readmissions Have Been Overstated. (2019) (105)
Games Hospitals Play: Entry Deterrence in Hospital Procedure Markets (2005) (91)
The Impact of Tort Reform on Employer-Sponsored Health Insurance Premiums (2009) (81)
Changes in Quality of Care after Hospital Mergers and Acquisitions. (2020) (71)
The price effects of cross‐market mergers: theory and evidence from the hospital industry (2019) (59)
Narrow Networks On The Health Insurance Marketplaces: Prevalence, Pricing, And The Cost Of Network Breadth. (2017) (56)
The Price Effects of Cross-Market Hospital Mergers (2016) (53)
Let Them Have Choice: Gains from Shifting Away from Employer-Sponsored Health Insurance and Toward an Individual Exchange (2010) (52)
Designing transparency systems for medical care prices. (2011) (42)
When Discounts Raise Costs: The Effect of Copay Coupons on Generic Utilization (2016) (37)
Evaluating the Impact of Health Insurance Industry Consolidation: Learning from Experience. (2015) (36)
The good merger. (2015) (34)
Changes in Quality of Care after Hospital Mergers and Acquisitions. (2020) (32)
Data Impediments to Empirical Work on Health Insurance Markets (2011) (31)
Does Public Insurance Improve the Efficiency of Medical Care? Medicaid Expansions and Child Hospitalizations (2000) (29)
Regulatory Exploitation and Management Changes: Upcoding in the Hospital Industry (2009) (26)
Narrow Networks on the Health Insurance Exchanges: What Do They Look Like and How Do They Affect Pricing? A Case Study of Texas. (2015) (26)
Undermining Value-Based Purchasing - Lessons from the Pharmaceutical Industry. (2016) (24)
Health Care Needs Real Competition (2016) (22)
Do report cards tell consumers anything they don't know already? The case of Medicare HMOs. (2008) (17)
Does it Matter If Your Health Insurer is For-Profit? Effects of Ownership on Premiums, Insurance Coverage, and Medical Spending (2012) (17)
Treatment Of Opioid Use Disorder Among Commercially Insured US Adults, 2008-17. (2020) (15)
Economics at the FTC: Physician Acquisitions, Standard Essential Patents, and Accuracy of Credit Reporting (2013) (13)
How Does Competition Impact the Quality of Health Care? A Case Study of the U.S. Dialysis Industry (2012) (10)
New Marketplace Survey: The Sources of Health Care Innovation (2017) (8)
An Individual Health Plan Exchange: Which Employees Would Benefit and Why? (2010) (7)
Regulatory Exploitation and the Market for Corporate Controls (2006) (6)
How Does Competition Impact the Quality and Price of Outpatient Service Facilities? A Case Study of the U.S. Dialysis Industry (2015) (5)
Entry Deterrence in Hospital Procedure Markets: A Simple Model of Learning-by-Doing (2003) (5)
How Does Competition Impact Quality of Care? A Case Study of the U.S. Dialysis Industry (2014) (5)
Are Health Insurance Markets Competitive ? A Test of Direct Price Discrimination (2007) (4)
Primary Care Is Hurting: Why Aren't Private Insurers Pitching In? (2020) (4)
Does CVS-Aetna Spell the End of Business as Usual? (2018) (4)
Addressing Consolidation in Health Care Markets. (2021) (4)
A Radical Treatment for Insulin Pricing. (2022) (3)
Regulating Hospital Prices Based On Market Concentration Is Likely To Leave High-Price Hospitals Unaffected. (2021) (3)
A Competitive Process for Procuring Health Services: A Review of Principles with an Application to Cataract Services (2009) (3)
How Has Covid-19 Affected Health Insurance Offered by Small Businesses in the U.S.? Early Evidence from a Survey (2020) (2)
More Insurers Lower Premiums (2015) (2)
New Marketplace Survey: Physicians and Hospitals Differ on How toReduce Costs (2016) (2)
Do Policies to Increase Access to Treatment for Opioid Use Disorder Work? (2021) (2)
The Price Effects of Cross-Market Mergers (2017) (2)
Vertical Integration of Healthcare Providers Increases Self-Referrals and Can Reduce Downstream Competition: The Case of Hospital-Owned Skilled Nursing Facilities (2020) (2)
Who Will Succeed with New Payment Models? Part 2 (2017) (1)
Changes in Quality of Care after Hospital Mergers and Acquisitions. Reply. (2020) (1)
1 How Do Hospitals Respond To Price Changes ? (2005) (1)
Health Care Industry Consolidation (2018) (1)
Narrow Networks on the Health Insurance Marketplaces: What Hospitals are In or Out and How Does it Affect Premiums and Consumer Choices? (2016) (1)
Price Effects of Hospital Mergers When the Hospitals are in Different Markets (2014) (1)
Are For-Profit Insurers Different? (2011) (1)
The Road to Successful Bundled Payment Risk (2016) (1)
EXPANDING CHOICE IN EMPLOYER-SPONSORED HEALTH INSURANCE: WHO GAINS AND WHY? (2009) (1)
New Marketplace Survey: What’s Next for Payment Reform? (2017) (1)
Good Riddance to Big Insurance Mergers. (2017) (1)
The impact of market forces and public health insurance on inpatient care (2001) (0)
Fair Pharma? Intermountain’s New Generic Drug Company (2018) (0)
Private Sector Pitfalls in U.S. Health Care (2019) (0)
Are For-Profit Insurers Different? Leemore Dafny Northwestern University and NBER (2011) (0)
Private health insurance markets (2012) (0)
When Do Provider-Sponsored Health Plans Make Sense? Part 2 (2016) (0)
Three Key Ingredients to a Healthy Marketplace (2016) (0)
Why Health Care Isn’t Staples or Starbucks (2017) (0)
Amazon and CVS: Short-Lived Unicorns in Health Care, or Healers ofthe “Tapeworm”? (2018) (0)
Reshaping Care Coverage: A Public Good Problem (2018) (0)
Oscar Health Insurance: What Lies Ahead for a Unicorn Insurance Entrant? (2018) (0)
Do For-Profit Insurers Charge Higher Premiums ? (2011) (0)
New Marketplace Survey: Value-Based Payment Gains Traction AmidActive M&A Environment (2016) (0)
Acknowledgement of Reviewers for AJHE During 2017 (2018) (0)
Resolving the Payer-Employer Disconnect (2018) (0)
Economics at the FTC: Physician Acquisitions, Standard Essential Patents, and Accuracy of Credit Reporting (2013) (0)
Treatment Of Opioid Use Disorder Among Commercially Insured Adults In The U.S. (2020) (0)
NBER WORKING PAPER SERIES REGULATORY EXPLOITATION AND THE MARKET FOR CORPORATE CONTROL (2006) (0)
Jumping into Value-Based Reimbursement with Two Feet (2017) (0)
New Marketplace Survey: Why Medicaid Is Still Broken (2016) (0)
Why Employers Drag Feet on Value-Based Insurance (2018) (0)
Innovation vs. Imitation: Staying Ahead of the Game (2016) (0)
Giving A Buck Or Making A Buck? Donations By Pharmaceutical Manufacturers To Independent Patient Assistance Charities. (2022) (0)
NBER WORKING PAPER SERIES INSURER COMPETITION AND NEGOTIATED HOSPITAL PRICES (2013) (0)
Healthy Competition → Healthy Marketplace (2015) (0)
Organizations and Market Structure (2014) (0)
Rules of Business = Rules of Health Care (2017) (0)
New Marketplace Survey: Patients Lack Information to Reduce theCost of Care (2019) (0)
Payment Reform Is a Play We’re All Watching (2017) (0)
APPENDIX FOR “ AN INDIVIDUAL HEALTHPLAN EXCHANGE : WHICH EMPLOYEES WOULD BENEFIT AND WHY ? ” (2010) (0)
Designating Certain Post-Acute Care Facilities As COVID-19 Skilled Care Centers Can Increase Hospital Capacity And Keep Nursing Home Patients Safer (2020) (0)
Editorial: Relaunch of the journal (2015) (0)
NBER WORKING PAPER SERIES HOW DO COPAYMENT COUPONS AFFECT BRANDED DRUG PRICES AND QUANTITIES PURCHASED? Leemore Dafny (2022) (0)
Transforming the Health Care Marketplace (2016) (0)
Prescription for an Ailing U.S. Health Care Market (2018) (0)
Has the ACA Discouraged Innovation (2017) (0)
Sculpting the Pieta of Health Care (2016) (0)
Panel Discussion: Health Policy and the 2020 Presidential Candidates (2020) (0)
Acknowledgment of Reviewers for AJHE during 2016 (2017) (0)
Falling Insulin Prices - What Just Happened? (2023) (0)
What Role Can a State Play in Cost & Quality? (2016) (0)
Overcoming the Fear of Doing Something Different (2016) (0)
New Entrants: Friends or Foes? (2016) (0)
China’s Changing Health Care: Global Lessons at Scale (2019) (0)
Generic Drug Competition (2016) (0)
How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased? (2022) (0)
Treatment for Commercially Insured Patients with Opioid Use Disorder in the U.S.: What Are We Doing, and What Should We Be Doing? (2019) (0)

This paper list is powered by the following services:

Other Resources About Leemore Dafny

en.wikipedia.org

What Schools Are Affiliated With Leemore Dafny?

Leemore Dafny is affiliated with the following schools: